Irish Life Investment Managers’s PDL BioPharma, Inc. PDLI Stock Holding History

Irish Life Investment Managers’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q2	$46.3K	Buy	+6,006	New	+$46.8K	﹤0.01%	1446

Other funds holding PDLI

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Irish Life Investment Managers's PDLI Position: Q2 2013 in Review

Irish Life Investment Managers opened a new position in PDL BioPharma, Inc. (PDLI) in Q2 2013: 6,006 shares worth $46.3K. The stake represents ﹤0.01% of the portfolio and ranks #1446 among its holdings.

202 funds tracked by Wall St. Rank hold PDLI as of Q2 2013.

Irish Life Investment Managers held 6,006 shares of PDL BioPharma, Inc. worth $46.3K as of Q2 2013.
PDL BioPharma, Inc. was a new Irish Life Investment Managers position in Q2 2013.
PDL BioPharma, Inc. made up ﹤0.01% of Irish Life Investment Managers's portfolio in Q2 2013, its #1446 holding.
202 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2013.

Based on Irish Life Investment Managers's 13F filing for Q2 2013, filed 13 Aug 2013.